Dataset Information

Evaluating a shared model of cancer follow-up care between general practitioners and radiation oncologists, for patients with breast, prostate or colorectal cancer.

ABSTRACT: Interventions: 1. Intervention name Shared model of cancer follow-up care between general practitioners and radiation oncologists, for patients with breast, prostate or colorectal cancer. 2. Why The rising incidence of cancer and increasing number of cancer survivors has resulted in the need to find alternative models of care for cancer follow-up care. The acceptability for follow-up care in general practice is growing, and acceptance increases with shared-care models where oncologists are still overseeing care. However, a major barrier to this model is the effective two-way exchange of information in real-time between oncologists and general practitioners. Improved communication technology plays an important role in the acceptability and feasibility of cancer shared follow-up care. 3. What The intervention is additional radiation oncology follow-up appointments for the patient with their general practitioner; whilst the radiation oncologist is informed in real-time via the hospital oncology information system (electronic record). Digital health technology (PROsaiq) will be used to transfer the review information from the general practitioner directly into the hospital system. The radiation oncologist will oversee the care by accessing the review information directly, and identify if the patient needs any further medical intervention or support. 4. Who provided The general practitioner will complete a two hour radiation oncology course online (eviQ). A 30-minute training session will be provided by a radiation oncologist directly to the general practitioner on how to access the clinical assessment link, and what to do during the follow-up review by a radiation oncologist (review sleep, weight, skin reactions, bladder/bowel, prostate blood leve Primary outcome(s): Assessment of patient-perceived acceptability and feasibility of the intervention using semi-structured interviews. One on one phone and audio-recorded. [Baseline before intervention; and 6-months post-enrolment (immediately after the second intervention appointment). ];Assessment of general practitioner-perceived acceptability and feasibility of the intervention using semi-structured interviews. One on one phone and audio-recorded. [Baseline before intervention; and 6-months post-enrolment (immediately after the second intervention appointment). ];Assessment of radiation oncologist-perceived acceptability and feasibility of the intervention using semi-structured interviews. One on one phone and audio-recorded. [Baseline before intervention; and 6-months post-enrolment (immediately after the second intervention appointment). ] Study Design: Purpose: Educational / counselling / training; Allocation: Non-randomised trial; Assignment: Single group

DISEASE(S): Colorectal Cancer,Cancer-prostate,Prostate Cancer,Cancer-bowel-back Passage (rectum) Or Large Bowel (colon),Breast Cancer,Cancer-breast

PROVIDER: 2471300 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Similar Datasets

Project description:Interventions: For this group of patients for whom surgery is palliative, the two different treatment intervention arms are as follows: a) the standard practice of initially undergoing surgery to remove the primary cancer followed by chemotherapy and/or radiotherapy, or b) treatment with chemotherapy and/or radiotherapy alone, reserving surgery until such a time as disease progression results in bowel complications, and surgery to remove the primary tumour must be performed. In the first group, surgery to remove the tumour will be performed by open laparotomy and resection, or by laparoscopic (keyhole) resection as per the surgeon’s standard practice. Chemotherapy or chemoradiotherapy to follow involves a full course of systemic chemotherapy where systemic therapy comprises optimal treatment as judged by the treating oncologist/radiation oncologist. Treatment may include experimental agents and patients may participate in other chemotherapy clinical trials. Primary outcome(s): The primary outcome is to determine whether surgical resection of the primary tumour in patients with stage IV colorectal cancer decreases intestinal complications and improves overall survival and quality of life.[Patients’ clinical status and cancer history and baseline quality of life assessment will be completed within 4 weeks prior to randomisation. Morbidity/mortality data will be collected for patients randomised to surgical intervention, including endoscopy as well as any patients who require emergent surgical intervention at any timepoint. A review of patients monthly for six months then every 3 months until death, either at a corresponding visit to the treating surgeon/oncologist or phone call by the study co-coordinator, will be done to determine if intestinal complications have occurred. At 1,2,3,4,5,and 6 months, quality of life questionnaires repeated. Overall survival will be measured from the date of randomisation to date of death from any cause.] Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Safety/efficacy

Dataset Information

Evaluating a shared model of cancer follow-up care between general practitioners and radiation oncologists, for patients with breast, prostate or colorectal cancer.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure